Sanofi (BIT:1SAN)

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 106.59 billion. The enterprise value is 119.71 billion.

Market Cap	106.59B
Enterprise Value	119.71B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	1.22B
Shares Outstanding	n/a
Shares Change (YoY)	-1.65%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	58.10%
Float	1.10B

Valuation Ratios

The trailing PE ratio is 11.70 and the forward PE ratio is 10.67.

PE Ratio	11.70
Forward PE	10.67
PS Ratio	2.32
PB Ratio	1.45
P/TBV Ratio	24.25
P/FCF Ratio	11.36
P/OCF Ratio	9.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.40, with an EV/FCF ratio of 12.76.

EV / Earnings	13.14
EV / Sales	2.61
EV / EBITDA	9.40
EV / EBIT	12.35
EV / FCF	12.76

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.30.

Current Ratio	1.06
Quick Ratio	0.29
Debt / Equity	0.30
Debt / EBITDA	1.72
Debt / FCF	2.32
Interest Coverage	24.55

Financial Efficiency

Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 6.25%.

Return on Equity (ROE)	8.84%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.25%
Return on Capital Employed (ROCE)	9.83%
Revenue Per Employee	554,200
Profits Per Employee	109,957
Employee Count	82,878
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sanofi has paid 1.53 billion in taxes.

Income Tax	1.53B
Effective Tax Rate	19.14%

Stock Price Statistics

The stock price has decreased by -10.88% in the last 52 weeks. The beta is 0.44, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-10.88%
50-Day Moving Average	83.48
200-Day Moving Average	90.81
Relative Strength Index (RSI)	60.49
Average Volume (20 Days)	7,562

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 45.93 billion and earned 9.11 billion in profits. Earnings per share was 7.39.

Revenue	45.93B
Gross Profit	33.07B
Operating Income	9.60B
Pretax Income	8.01B
Net Income	9.11B
EBITDA	12.33B
EBIT	9.60B
Earnings Per Share (EPS)	7.39

Balance Sheet

The company has 8.91 billion in cash and 21.76 billion in debt, giving a net cash position of -12.85 billion.

Cash & Cash Equivalents	8.91B
Total Debt	21.76B
Net Cash	-12.85B
Net Cash Per Share	n/a
Equity (Book Value)	73.53B
Book Value Per Share	60.15
Working Capital	1.94B

Cash Flow

In the last 12 months, operating cash flow was 11.12 billion and capital expenditures -1.73 billion, giving a free cash flow of 9.38 billion.

Operating Cash Flow	11.12B
Capital Expenditures	-1.73B
Free Cash Flow	9.38B
FCF Per Share	n/a

Margins

Gross margin is 72.00%, with operating and profit margins of 20.90% and 19.84%.

Gross Margin	72.00%
Operating Margin	20.90%
Pretax Margin	17.43%
Profit Margin	19.84%
EBITDA Margin	26.85%
EBIT Margin	20.90%
FCF Margin	20.43%

Dividends & Yields

This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 4.46%.

Dividend Per Share	3.92
Dividend Yield	4.46%
Dividend Growth (YoY)	4.26%
Years of Dividend Growth	1
Payout Ratio	51.62%
Buyback Yield	1.65%
Shareholder Yield	6.11%
Earnings Yield	8.55%
FCF Yield	8.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4